Hematologic Malignancies

Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for different types of hematologic malignancies including lymphomas, leukemia, and myeloma. We guarantee the finest results for our customers all over the world.

Hematologic Malignancies - Creative Biolabs

Hematologic cancers, including lymphomas (Hodgkin and non-Hodgkin), leukemias (acute lymphoid, acute myeloid, and chronic lymphocytic), and plasma cell cancers (multiple myeloma and WaldEnstrom’s macroglobulinemia) hold a special place in the history of cancer immunotherapy development. Hematologic malignancies, as cancers of immune cells themselves, represent a unique setting and challenge to immunotherapy: we must turn the immune system “on itself” to fight malignant forms of leukocytes. In this lies the challenge to exploit antigenic, genetic, and phenotypic differences between normal and transformed cells, most often pitting effector and target cells of the same lymphoid lineage against each other. The most advanced research efforts for vaccine therapies in hematologic malignancies have focused on tumor-specific idiotype vaccines for B cell lymphomas.


Lymphoma is a group of hematological cancers that develop from lymphocytes, a type of white blood cell. There are dozens of subtypes of lymphomas. The two main categories of lymphomas are Hodgkin's lymphomas (HL) and the non-Hodgkin lymphomas (NHL). Signs and symptoms may include fever, swollen lymph nodes, excessive dribbling, unexpected weight loss, and constant tiredness. Treatment may involve some combination of chemotherapy, radiotherapy, targeted therapies, and surgery.


Leukemia is a type of cancer arising from the bone marrow and causes a large number of abnormal white blood cells. These white blood cells are not fully developed and are known as blast cells or leukemic cells. The four main categories of leukemia are Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML), Chronic lymphocytic leukemia (CLL) and Chronic myeloid leukemia (CML). The exact cause of leukemia is unknown. It is believed that a combination of genetic and environmental (non-genetic) factors play a role in leukemia.


Multiple myeloma, also known as plasma cell myeloma, is a type of plasma cell cancer. Multiple myeloma is considered to be treatable but incurable. Chemotherapy, thalidomide or lenalidomide and stem cell transplantation may alleviate the condition. Vaccine therapy can be used to maintain remission and prolong the survival of multiple myeloma, particularly when combined with other immunotherapies.

Creative Biolabs is a leader in the field of vaccine development and has focused on the cancer vaccines for years. We have experts who are able to help you with the vaccine development for different types of hematologic malignancies. If you are interested in our services, please contact us for more details.

Our services are for Research Use Only. We do not provide services to individuals.

Online Inquiry

For Research Use Only | Do Not Use in Humans.

*E-mail Address:
*Products or Services Interested:
Project Description:





Follow us on

facebook   twitter   linked   blog

Shopping Basket